How often can midazolam (Versed) be used for acute seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Midazolam Dosing Frequency for Acute Seizures

Midazolam can be repeated every 5-10 minutes for ongoing seizures, with a maximum of 2-3 doses before escalating to alternative therapies or seeking emergency care. 1, 2

Initial Dosing by Route

Intravenous/Intraosseous Administration

  • Pediatric patients (<6 months): Titrate with small increments starting at 0.05 mg/kg due to high risk of airway obstruction and hypoventilation 3
  • Pediatric patients (6 months-5 years): 0.05-0.1 mg/kg initially, up to 0.6 mg/kg total (usually not exceeding 6 mg) 3
  • Pediatric patients (6-12 years): 0.025-0.05 mg/kg initially, up to 0.4 mg/kg total (usually not exceeding 10 mg) 3
  • Adolescents/Adults (≥12 years): Dose as adults, usually not exceeding 10 mg total 3

Intramuscular Administration

  • Dose: 0.1-0.15 mg/kg (up to 0.2 mg/kg has been studied effectively) 4, 5, 6
  • Onset: Seizure arrest typically occurs within 5-10 minutes 4
  • Advantage: Rapidly absorbed due to water solubility, easier than IV access during active seizures 4

Nasal/Buccal Administration

  • Buccal midazolam: Equally effective as rectal diazepam with 75% efficacy rate 7
  • Timing: Monitor for 10 minutes after administration before considering additional doses 7

Repeat Dosing Protocol

Timing Between Doses

  • IV/IO route: Repeat every 5 minutes as needed 1, 3
  • IM route: If initial dose fails, can transition to IV administration rather than repeat IM 8
  • Nasal/buccal route: If seizures continue after 10 minutes, administer second dose 2, 7

Maximum Dosing

  • After 2 doses: If seizures persist, seek emergency medical care and consider alternative anticonvulsants 2
  • Continuous infusion: For refractory seizures in intubated patients, loading dose of 0.05-0.2 mg/kg over 2-3 minutes, followed by continuous infusion 3

Critical Safety Considerations

Respiratory Monitoring

  • Monitor oxygen saturation and respiratory status continuously, especially with repeat dosing 2, 7
  • Higher doses (>0.4 mg/kg) carry increased risk of prolonged sedation and hypoventilation 3
  • Each dose must be administered slowly over 2-3 minutes to allow full evaluation of sedative effect before repeating 3

Common Pitfall to Avoid

Do not repeat doses too quickly. Midazolam takes approximately 3 times longer than diazepam to achieve peak EEG effects, requiring a 2-3 minute wait between doses to fully evaluate the sedative effect 3. Premature repeat dosing significantly increases respiratory depression risk.

Transition to Long-Acting Anticonvulsants

  • Midazolam should be followed immediately by a long-acting anticonvulsant such as phenytoin/fosphenytoin or oral carbamazepine, as benzodiazepines are rapidly redistributed and seizures often recur within 15-20 minutes 1, 8

Dose Reduction Required

  • Patients on concomitant CNS depressants (including opioids) require reduced midazolam doses 2, 3
  • Hepatic impairment necessitates dose reduction due to decreased clearance 2
  • Higher risk or debilitated patients require lower dosages regardless of concomitant medications 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Midazolam Nasal Spray for Acute Seizure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Use of intramuscular midazolam for status epilepticus.

The Journal of emergency medicine, 1999

Research

Midazolam in treatment of epileptic seizures.

Pediatric neurology, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.